Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat

Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...

ver descrição completa

Detalhes bibliográficos
Autor principal: Teixeira, M. (author)
Outros Autores: Rodrigues-Santos, P. (author), Garrido, P. (author), Costa, E. (author), Parada, B. (author), Sereno, J. (author), Alves, R. (author), Belo, L. (author), Teixeira, F. (author), Santos-Silva, A. (author), Reis, F. (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Apoptosis
Cardiovascular protection
Gene expression
Moderate chronic renal failure
Proliferation/angiogenesis
Texto completo:http://hdl.handle.net/10400.14/35042
País:Portugal
Oai:oai:repositorio.ucp.pt:10400.14/35042

Texto Completo

http://hdl.handle.net/10400.14/35042

Registos relacionados